Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionDeutsche Bank Ag\
Latest Disclosed Ownership1,537,736 shares
Latest Disclosed Value $ 686,660,634
Deutsche Bank Ag\ ownership in VRTX / Vertex Pharmaceuticals Incorporated

On May 6, 2026 - Deutsche Bank Ag\ filed a 13F-HR form disclosing ownership of 1,537,736 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $686,660,633 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 1,768,881 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -13.07% during the quarter. The current value of the position is $687,106,577 USD.

Deutsche Bank Ag\ has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,537,736 -231,145 -13.07 686,661 -14.38 0.2269
2026-02-11 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,768,881 168,425 10.52 801,940 27.94 0.2611
2025-11-13 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,600,456 192,822 13.70 626,803 0.02 0.2100
2025-08-12 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,407,634 60,748 4.51 626,679 -4.03 0.2307
2025-05-09 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,346,886 -42,719 -3.07 652,997 16.69 0.2588
2025-06-30 2024-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,389,605 76,695 5.84 559,594 -8.35 0.2191
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,389,605 76,695 559,594 0.2184
2025-06-26 2024-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,312,910 -66,410 -4.81 610,608 -5.55 0.2485
2024-11-13 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,312,910 -66,410 610,608 0.2485
2025-06-12 2024-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,379,320 -197,541 -12.53 646,515 -1.92 0.2917
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,379,320 -197,541 646,515 0.2917
2025-06-02 2024-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,576,861 -69,804 -4.24 659,144 -1.62 0.3059
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,576,861 -69,804 659,144 0.3060
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,646,665 320,297 24.15 670,012 45.27 0.3418
2023-11-24 2023-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,326,368 -270,232 -16.93 461,231 -17.91 0.2978
2023-11-09 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,326,368 -270,232 461,231 0.2552
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,596,600 -159,560 -9.09 561,860 1.54 0.2987
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,756,160 -96,922 -5.23 553,313 3.40 0.3081
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,853,082 25,625 1.40 535,133 1.14 0.3080
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,827,457 -213,715 -10.47 529,123 -8.01 0.3194
2022-08-11 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,041,172 -107,454 -5.00 575,181 2.58 0.3210
2022-05-13 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,148,626 -410,687 -16.05 560,726 -0.23 0.2616
2022-02-16 2021-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,559,313 -127,278 -4.74 562,024 15.33 0.2527
2022-02-11 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,559,313 -127,278 562,024 0.2521
2021-11-04 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,686,591 -47,319 -1.73 487,320 -11.60 0.2312
2021-08-11 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,733,910 694,871 34.08 551,238 25.80 0.2677
2021-05-13 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,039,039 783,218 62.37 438,169 47.63 0.2360
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,255,821 236,046 23.15 296,801 6.95 0.1812
2020-11-12 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,019,775 116,703 12.92 277,501 5.85 0.1909
2020-08-13 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 903,072 -36,239 -3.86 262,170 17.30 0.1993
2020-05-14 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 939,311 -532,686 -36.19 223,510 -30.65 0.1995
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,471,997 -7,738 -0.52 322,288 28.56 0.2100
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,479,735 -320,786 -17.82 250,691 -24.07 0.1741
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,800,521 403,803 28.91 330,174 28.51 0.1938
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,396,718 432,709 44.89 256,919 60.84 0.1530
2019-04-01 2018-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 964,009 -332,854 -25.67 159,740 -36.09 0.1133
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 964,009 116,533 159,740
2021-12-21 2018-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,296,863 -84,362 -6.11 249,957 6.48 0.1264
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 847,476 -533,749 163,339 0.1129
2020-04-21 2018-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,381,225 41,544 3.10 234,754 7.52 0.1169
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,005,348 -334,333 170,863 113,486.7788
2019-10-23 2018-03-31 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 1,339,681 407,204 43.67 218,338 56.25 0.1042
2019-10-18 2018-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,339,681 0 218,338 0.1042
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 736,288 -196,189 119,999
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 932,477 -59,309 -5.98 139,735 -7.33 0.0895
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 991,786 205,898 26.20 150,787 48.89 0.1033
2017-08-11 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 785,888 -388,987 -33.11 101,272 -21.17 0.0723
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,174,875 40,805 3.60 128,468 53.78 0.0949
2017-02-14 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,134,070 -194,159 -14.62 83,542 -27.88 0.0672
2016-11-14 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,328,229 -54,153 -3.92 115,830 -2.59 0.0820
2016-08-15 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,382,382 187,908 15.73 118,910 25.24 0.0840
2016-05-16 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,194,474 -102,111 -7.88 94,943 -41.80 0.0715
2016-02-16 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,296,585 334,954 34.83 163,145 62.92 0.1129
2015-11-17 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 961,631 -206,384 -17.67 100,140 -30.57 0.0774
2015-08-12 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,168,015 54,317 4.88 144,223 9.78 0.0921
2015-05-15 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,113,698 -67,699 -5.73 131,380 -6.39 0.0817
2015-02-13 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,181,397 -1,252,621 -51.46 140,346 -48.66 0.0866
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,434,018 233,581 10.62 273,361 31.21 0.1697
2014-08-15 2014-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,200,437 -31,561 -1.41 208,332 31.99 0.1415
2014-05-15 2014-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,231,998 825,842 58.73 157,843 51.09 0.1121
2014-02-24 2013-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,406,156 -193,073 -12.07 104,472 -13.84 0.0751
2014-02-18 2013-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,406,156 104,472
2013-11-18 2013-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,599,229 521,804 48.43 121,251 40.57 0.0895
2013-08-16 2013-06-30 13F VERTEX PHARMACEUTICALS COM 092532F10 1,077,425 1,077,425 86,254 0.0707
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-14 2020-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM Call 65 0.00 14 27.27 n/a n/a n/a
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM Call 65 0.00 11 0.00 n/a n/a n/a
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM Call 65 0.00 11 0.00 n/a n/a n/a
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM Call 65 0.00 11 10.00 n/a n/a n/a
2019-04-01 2018-12-31 13F/A VERTEX PHARMACEUTICALS COM Call 65 -80.54 10 -84.62 n/a n/a n/a
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM Call 65 10 n/a n/a n/a
2021-12-21 2018-09-30 13F/A VERTEX PHARMACEUTICALS COM Call 334 413.85 65 490.91 n/a n/a n/a
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM Call 334 63 n/a n/a n/a
2020-04-21 2018-06-30 13F/A VERTEX PHARMACEUTICALS COM Call 65 0.00 11 10.00 n/a n/a n/a
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM Call 65 11 n/a n/a n/a
2019-10-18 2018-03-31 13F/A VERTEX PHARMACEUTICALS COM Call 65 10 n/a n/a n/a
2019-10-23 2018-03-31 13F/A VERTEX PHARMACEUTICALS COM Call 65 0.00 10 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS COM Call 65 10 n/a n/a n/a
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-11 2017-06-30 13F VERTEX PHARMACEUTICALS COM Call 129 16 n/a n/a n/a
2015-05-15 2015-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-13 2014-12-31 13F VERTEX PHARMACEUTICALS COM Call 1,600 0.00 190 6.15 n/a n/a n/a
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS COM Call 1,600 -81.40 179 -78.01 n/a n/a n/a
2014-08-15 2014-06-30 13F VERTEX PHARMACEUTICALS COM Call 8,602 30.14 814 3,156.00 n/a n/a n/a
2014-05-15 2014-03-31 13F VERTEX PHARMACEUTICALS COM Call 6,610 -80.07 25 -95.57 n/a n/a n/a
2014-02-24 2013-12-31 13F/A VERTEX PHARMACEUTICALS COM Call 33,166 -9.30 564 -27.78 n/a n/a n/a
2014-02-18 2013-12-31 13F VERTEX PHARMACEUTICALS COM Call 33,166 564 n/a n/a n/a
2013-11-18 2013-09-30 13F VERTEX PHARMACEUTICALS COM Call 36,566 14.98 781 -10.44 n/a n/a n/a
2013-08-16 2013-06-30 13F VERTEX PHARMACEUTICALS COM Call 31,802 872 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-05-15 2015-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-13 2014-12-31 13F VERTEX PHARMACEUTICALS COM Put 31,003 0.14 3,683 5.92 n/a n/a n/a
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS COM Put 30,961 17.43 3,477 39.30 n/a n/a n/a
2014-08-15 2014-06-30 13F VERTEX PHARMACEUTICALS COM Put 26,366 118.57 2,496 2,347.06 n/a n/a n/a
2014-05-15 2014-03-31 13F VERTEX PHARMACEUTICALS COM Put 12,063 -3.98 102 -12.07 n/a n/a n/a
2014-02-24 2013-12-31 13F/A VERTEX PHARMACEUTICALS COM Put 12,563 33.49 116 43.21 n/a n/a n/a
2014-02-18 2013-12-31 13F VERTEX PHARMACEUTICALS COM Put 12,563 116 n/a n/a n/a
2013-11-18 2013-09-30 13F VERTEX PHARMACEUTICALS COM Put 9,411 3.04 81 145.45 n/a n/a n/a
2013-08-16 2013-06-30 13F VERTEX PHARMACEUTICALS COM Put 9,133 33 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.